DNA Virus Infections clinical trials
The registry lists 20 studies for DNA Virus Infections across more than 10 countries. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-10-13.
Keep track of what changes. Save the DNA Virus Infections studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWho runs them
ModernaTX, Inc. (4) · Jiangsu Province Centers for Disease Control and Prevention (2) · AusperBio Therapeutics Inc. (2) · Shenzhen Shenxin Biotechnology Co., Ltd (2) · Lower Saxony Center for Nephrology (1) · Christian von Buchwald (1) · Merck Sharp & Dohme LLC (1) · National Cancer Institute (NCI) (1)
Who these studies take
Of the 4 DNA Virus Infections studies recruiting now, 2 (50%) set no upper age limit and 2 (50%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (25%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 3 (75%) | 3 (75%) |
| 30 | 3 (75%) | 3 (75%) |
| 40 | 4 (100%) | 4 (100%) |
| 50 | 4 (100%) | 4 (100%) |
| 65 | 4 (100%) | 4 (100%) |
| 75 | 2 (50%) | 2 (50%) |
| 85 | 2 (50%) | 2 (50%) |
Across all 20 studies, recruiting or not: 50% stop at 75 or younger and 45% at 65; 20% take children; 15% are for women only and 0% for men only; 35% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 20 of 20. search them.
- Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific RegionRecruitingNCT07370207Phase 27 countries
- Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe RegionsRecruitingNCT07654283Phase 26 countries
- Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx CancerRecruitingNCT05388773Phase 21 country
- Long-term Effectiveness of the Live Attenuated Herpes Zoster VaccineRecruitingNCT075853701 country
- A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy ParticipantsNot yet recruitingNCT07205796Phase 2
- Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)Active, not recruitingNCT05797246Phase 21 country
- A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.Active, not recruitingNCT05683457Phase 21 country
- Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy AdultsCompletedNCT04232280Phase 21 country
- A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy ParticipantsCompletedNCT06375512Phase 12 countries
- A Long-Term Extension Study to Evaluate the Immunogenicity and Safety of Cytomegalovirus (CMV) mRNA-1647 VaccineCompletedNCT04975893Phase 21 country
- Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell CarcinomaActive, not recruitingNCT04124198Not applicable1 country
- A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of AgeTerminatedNCT05085366Phase 313 countries
- HPV Self-Sampling in Somali Women (Isbaar Project)CompletedNCT05453006Not applicable1 country
- Cantharidin and Occlusion in Verruca EpitheliumCompletedNCT03487549Phase 21 country
- ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)CompletedNCT01600079
- DNA and RNA Viruses of the Blood Virome of Allogeneic Hematopoietic Stem Cell Transplant RecipientsCompletedNCT036429771 country
- Studies of Small DNA Virus Encoded Oncogenes in Viral Carcinogenesis Using Laboratory Model SystemsStatus unknownNCT03188315Not applicable
- Epidemiological Study in Children and Adolescents With Chronic Hepatitis BCompletedNCT0116324018 countries
- The Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Health NeonatesCompletedNCT01183611Phase 31 country
- Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft RecipientsCompletedNCT00373165Phase 4